152 related articles for article (PubMed ID: 8400733)
1. The significance of 17 beta-estradiol levels in highly responding women during ovulation induction in IVF treatment: its impact and prognostic value with respect to oocyte maturation and treatment outcome.
Ben-Nun I; Shulman A; Ghetler Y; Shilon M; Kaneti H; Beyth Y
J Assist Reprod Genet; 1993 Apr; 10(3):213-5. PubMed ID: 8400733
[No Abstract] [Full Text] [Related]
2. 'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization.
Sher G; Zouves C; Feinman M; Maassarani G
Hum Reprod; 1995 Dec; 10(12):3107-9. PubMed ID: 8822423
[TBL] [Abstract][Full Text] [Related]
3. [Coasting: a response to excessive ovarian stimulation].
Dechaud H; Anahory T; Aligier N; Arnal F; Humeau C; Hédon B
Gynecol Obstet Fertil; 2000 Feb; 28(2):115-9. PubMed ID: 10758585
[TBL] [Abstract][Full Text] [Related]
4. Recovery and maturation of immature oocytes in patients at risk for ovarian hyperstimulation syndrome.
Coskun S; Jaroudi KA; Hollanders JM; Atared AM; Roca GL
J Assist Reprod Genet; 1998 Jul; 15(6):372-7. PubMed ID: 9673881
[TBL] [Abstract][Full Text] [Related]
5. Severe ovarian hyperstimulation syndrome after combined GnRH-agonist and low-dose human chorionic gonadotropin trigger in a patient with a single kidney.
Pereira N; Lekovich JP; Kligman I; Rosenwaks Z
Gynecol Endocrinol; 2017 Aug; 33(8):593-597. PubMed ID: 28440686
[TBL] [Abstract][Full Text] [Related]
6. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
[TBL] [Abstract][Full Text] [Related]
7. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
8. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
[TBL] [Abstract][Full Text] [Related]
9. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
Humaidan P; Ejdrup Bredkjaer H; Westergaard LG; Yding Andersen C
Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
[TBL] [Abstract][Full Text] [Related]
10. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.
Lu X; Hong Q; Sun L; Chen Q; Fu Y; Ai A; Lyu Q; Kuang Y
Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046
[TBL] [Abstract][Full Text] [Related]
11. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
Vrtovec HM; Tomazevic T
J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
[TBL] [Abstract][Full Text] [Related]
12. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
Zhu YM; Gao HJ; He RH; Huang HF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
[TBL] [Abstract][Full Text] [Related]
13. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
European Recombinant LH Study Group
J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
[TBL] [Abstract][Full Text] [Related]
14. Rescue hCG to treat empty follicle syndrome after the use of a GnRH agonist as oocyte maturation trigger: First report on fresh embryo transfer and clinical pregnancy.
Christopoulos G; Vlismas A; Barsoum-Derias E; El-Shawarby S; Trew G; Lavery S
Hum Fertil (Camb); 2015; 18(4):248-52. PubMed ID: 26400626
[TBL] [Abstract][Full Text] [Related]
15. Repeated aspiration of ovarian follicles and early corpus luteum cysts in an in-vitro fertilization programme reduces the risk of ovarian hyperstimulation syndrome in high responders.
Amit A; Yaron Y; Yovel I; Peyser MR; David MP; Botchan A; Lessing JB
Hum Reprod; 1993 Aug; 8(8):1184-6. PubMed ID: 8408514
[TBL] [Abstract][Full Text] [Related]
16. Blastocyst development and pregnancies after IVF of mature oocytes retrieved from unstimulated patients with PCOS after in-vivo HCG priming.
Son WY; Yoon SH; Lee SW; Ko Y; Yoon HG; Lim JH
Hum Reprod; 2002 Jan; 17(1):134-6. PubMed ID: 11756376
[TBL] [Abstract][Full Text] [Related]
17. Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome?
Lee C; Tummon I; Martin J; Nisker J; Power S; Tekpetey F
Hum Reprod; 1998 May; 13(5):1157-8. PubMed ID: 9647538
[TBL] [Abstract][Full Text] [Related]
18. A new approach to the management of patients at risk of ovarian hyperstimulation in an in-vitro fertilization programme.
Imoedemhe DA; Chan RC; Sigue AB; Pacpaco EL; Olazo AB
Hum Reprod; 1991 Sep; 6(8):1088-91. PubMed ID: 1806566
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
[TBL] [Abstract][Full Text] [Related]
20. Avoidance of cancellation of potential hyperstimulation cycles by conversion to in vitro fertilization-embryo transfer.
Lessing JB; Amit A; Libal Y; Yovel I; Kogosowski A; Peyser MR
Fertil Steril; 1991 Jul; 56(1):75-8. PubMed ID: 1906019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
